Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance
This study is currently recruiting participants.
Study NCT00004419   Information provided by FDA Office of Orphan Products Development
First Received: October 18, 1999   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Insulin Resistance
Hyperglycemia
More general conditions related to this trial
Glucose Metabolism Disorders
Hyperinsulinism
Metabolic Diseases
Interventions listed in this trial
insulin-like growth factor I
Additional drug interventions recognized in this trial
Insulin
Mitogens
More general drug interventions related to this trial
Hypoglycemic Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
FDA Office of Orphan Products Development
Beth Israel Deaconess Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services